Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07695948 · ClinicalTrials.gov registry record · Phase 3
Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors
A Phase 3 study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- Phase 3
- Development phase
- 252
- Enrollment target
NCT07695948 is a Phase 3 study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 252 participants.
The verdict
NCT07695948, a Phase 3 study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect, mediators and predictors of treatment response of acupuncture in treating the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) among breast cancer survivors.
Interventions
- BEHAVIORAL Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07695948
The ClinicalTrials.gov registry entry for NCT07695948 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT07695948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07695948 about?
NCT07695948 is a clinical study titled "Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors". The purpose of this study is to examine the effect, mediators and predictors of treatment response of acupuncture in treating the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) among breast cancer survivors.
What is the current status of trial NCT07695948?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 252 participants. The study started on 2026-09-01. Estimated completion is 2031-08-31.
What interventions are being tested in trial NCT07695948?
The interventions under investigation include: Acupuncture (BEHAVIORAL).
Who is sponsoring clinical trial NCT07695948?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.